A citation-based method for searching scientific literature

C Wyatt Shields, Michael A Evans, Lily Li-Wen Wang, Neil Baugh, Siddharth Iyer, Debra Wu, Zongmin Zhao, Anusha Pusuluri, Anvay Ukidve, Daniel C Pan, Samir Mitragotri. Sci Adv 2020
Times Cited: 100







List of co-cited articles
1500 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Human chimeric antigen receptor macrophages for cancer immunotherapy.
Michael Klichinsky, Marco Ruella, Olga Shestova, Xueqing Maggie Lu, Andrew Best, Martha Zeeman, Maggie Schmierer, Konrad Gabrusiewicz, Nicholas R Anderson, Nicholas E Petty,[...]. Nat Biotechnol 2020
306
25

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery.
Li Tang, Yiran Zheng, Mariane Bandeira Melo, Llian Mabardi, Ana P Castaño, Yu-Qing Xie, Na Li, Sagar B Kudchodkar, Hing C Wong, Emily K Jeng,[...]. Nat Biotechnol 2018
255
24

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.
Matthias T Stephan, James J Moon, Soong Ho Um, Anna Bershteyn, Darrell J Irvine. Nat Med 2010
417
21

Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence.
Jingwei Xue, Zekai Zhao, Lei Zhang, Lingjing Xue, Shiyang Shen, Yajing Wen, Zhuoyuan Wei, Lu Wang, Lingyi Kong, Hongbin Sun,[...]. Nat Nanotechnol 2017
374
18

Macrophages as regulators of tumour immunity and immunotherapy.
David G DeNardo, Brian Ruffell. Nat Rev Immunol 2019
649
14

Cell-based drug delivery devices using phagocytosis-resistant backpacks.
Nishit Doshi, Albert J Swiston, Jonathan B Gilbert, Maria L Alcaraz, Robert E Cohen, Michael F Rubner, Samir Mitragotri. Adv Mater 2011
102
13

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers.
F Zhang, N N Parayath, C I Ene, S B Stephan, A L Koehne, M E Coon, E C Holland, M T Stephan. Nat Commun 2019
156
13

Macrophage biology in development, homeostasis and disease.
Thomas A Wynn, Ajay Chawla, Jeffrey W Pollard. Nature 2013
13

The entry of nanoparticles into solid tumours.
Shrey Sindhwani, Abdullah Muhammad Syed, Jessica Ngai, Benjamin R Kingston, Laura Maiorino, Jeremy Rothschild, Presley MacMillan, Yuwei Zhang, Netra Unni Rajesh, Tran Hoang,[...]. Nat Mater 2020
501
13

Tumour-associated macrophages as treatment targets in oncology.
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena. Nat Rev Clin Oncol 2017
13

Macrophages with cellular backpacks for targeted drug delivery to the brain.
Natalia L Klyachko, Roberta Polak, Matthew J Haney, Yuling Zhao, Reginaldo J Gomes Neto, Michael C Hill, Alexander V Kabanov, Robert E Cohen, Michael F Rubner, Elena V Batrakova. Biomaterials 2017
66
18

Macrophage activation and polarization: nomenclature and experimental guidelines.
Peter J Murray, Judith E Allen, Subhra K Biswas, Edward A Fisher, Derek W Gilroy, Sergij Goerdt, Siamon Gordon, John A Hamilton, Lionel B Ivashkiv, Toby Lawrence,[...]. Immunity 2014
12

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
Christopher B Rodell, Sean P Arlauckas, Michael F Cuccarese, Christopher S Garris, Ran Li, Maaz S Ahmed, Rainer H Kohler, Mikael J Pittet, Ralph Weissleder. Nat Biomed Eng 2018
399
12

Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation.
Aaron C Anselmo, Jonathan B Gilbert, Sunny Kumar, Vivek Gupta, Robert E Cohen, Michael F Rubner, Samir Mitragotri. J Control Release 2015
88
12

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Sydney R Gordon, Roy L Maute, Ben W Dulken, Gregor Hutter, Benson M George, Melissa N McCracken, Rohit Gupta, Jonathan M Tsai, Rahul Sinha, Daniel Corey,[...]. Nature 2017
944
11

Enhancing cancer immunotherapy with nanomedicine.
Darrell J Irvine, Eric L Dane. Nat Rev Immunol 2020
220
11

Principles of nanoparticle design for overcoming biological barriers to drug delivery.
Elvin Blanco, Haifa Shen, Mauro Ferrari. Nat Biotechnol 2015
10

Nanoparticle-Laden Macrophages for Tumor-Tropic Drug Delivery.
Weizhong Zhang, Mengzhe Wang, Wei Tang, Ru Wen, Shiyi Zhou, Chaebin Lee, Hui Wang, Wen Jiang, Ian Michael Delahunty, Zipeng Zhen,[...]. Adv Mater 2018
81
12

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude.
Jacob S Brenner, Daniel C Pan, Jacob W Myerson, Oscar A Marcos-Contreras, Carlos H Villa, Priyal Patel, Hugh Hekierski, Shampa Chatterjee, Jian-Qin Tao, Hamideh Parhiz,[...]. Nat Commun 2018
128
10


CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Bin-Zhi Qian, Jiufeng Li, Hui Zhang, Takanori Kitamura, Jinghang Zhang, Liam R Campion, Elizabeth A Kaiser, Linda A Snyder, Jeffrey W Pollard. Nature 2011
9

Macrophages and therapeutic resistance in cancer.
Brian Ruffell, Lisa M Coussens. Cancer Cell 2015
791
9

Targeting Strategies for Tissue-Specific Drug Delivery.
Zongmin Zhao, Anvay Ukidve, Jayoung Kim, Samir Mitragotri. Cell 2020
145
9

Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.
Aaron C Anselmo, Vivek Gupta, Blaine J Zern, Daniel Pan, Michael Zakrewsky, Vladimir Muzykantov, Samir Mitragotri. ACS Nano 2013
188
9

Monocyte and macrophage heterogeneity.
Siamon Gordon, Philip R Taylor. Nat Rev Immunol 2005
9

Nanoparticles in the clinic: An update.
Aaron C Anselmo, Samir Mitragotri. Bioeng Transl Med 2019
498
9

Tumor-associated macrophages: from mechanisms to therapy.
Roy Noy, Jeffrey W Pollard. Immunity 2014
9

Macrophage-based cell therapies: The long and winding road.
Simon Lee, Saul Kivimäe, Aaron Dolor, Francis C Szoka. J Control Release 2016
83
10

Targeting macrophages: therapeutic approaches in cancer.
Luca Cassetta, Jeffrey W Pollard. Nat Rev Drug Discov 2018
668
9

Role of target geometry in phagocytosis.
Julie A Champion, Samir Mitragotri. Proc Natl Acad Sci U S A 2006
9

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.
Daniela Schmid, Chun Gwon Park, Christina A Hartl, Nikita Subedi, Adam N Cartwright, Regina Bou Puerto, Yiran Zheng, James Maiarana, Gordon J Freeman, Kai W Wucherpfennig,[...]. Nat Commun 2017
211
9


Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy.
Meixi Hao, Siyuan Hou, Weishuo Li, Kaiming Li, Lingjing Xue, Qifan Hu, Lulu Zhu, Yue Chen, Hongbin Sun, Caoyun Ju,[...]. Sci Transl Med 2020
30
30


Exploring the full spectrum of macrophage activation.
David M Mosser, Justin P Edwards. Nat Rev Immunol 2008
8

Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.
Bonnie Huang, Wuhbet D Abraham, Yiran Zheng, Sandra C Bustamante López, Samantha S Luo, Darrell J Irvine. Sci Transl Med 2015
170
8

Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis.
Zongmin Zhao, Anvay Ukidve, Yongsheng Gao, Jayoung Kim, Samir Mitragotri. Sci Adv 2019
56
14

Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy.
Quanyin Hu, Wujin Sun, Jinqiang Wang, Huitong Ruan, Xudong Zhang, Yanqi Ye, Song Shen, Chao Wang, Weiyue Lu, Ke Cheng,[...]. Nat Biomed Eng 2018
112
8

In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment.
Qian Chen, Chao Wang, Xudong Zhang, Guojun Chen, Quanyin Hu, Hongjun Li, Jinqiang Wang, Di Wen, Yuqi Zhang, Yifei Lu,[...]. Nat Nanotechnol 2019
355
8

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Amira A Barkal, Rachel E Brewer, Maxim Markovic, Mark Kowarsky, Sammy A Barkal, Balyn W Zaro, Venkatesh Krishnan, Jason Hatakeyama, Oliver Dorigo, Layla J Barkal,[...]. Nature 2019
378
8

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.
Padmanee Sharma, Siwen Hu-Lieskovan, Jennifer A Wargo, Antoni Ribas. Cell 2017
8

Delivery technologies for cancer immunotherapy.
Rachel S Riley, Carl H June, Robert Langer, Michael J Mitchell. Nat Rev Drug Discov 2019
726
8

Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment.
Yi Wang, Yao-Xin Lin, Sheng-Lin Qiao, Hong-Wei An, Yang Ma, Zeng-Ying Qiao, R P Yeshan J Rajapaksha, Hao Wang. Biomaterials 2017
149
8

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
Laura Bonapace, Marie-May Coissieux, Jeffrey Wyckoff, Kirsten D Mertz, Zsuzsanna Varga, Tobias Junt, Mohamed Bentires-Alj. Nature 2014
416
7

The M1 and M2 paradigm of macrophage activation: time for reassessment.
Fernando O Martinez, Siamon Gordon. F1000Prime Rep 2014
7

Artificially Reprogrammed Macrophages as Tumor-Tropic Immunosuppression-Resistant Biologics to Realize Therapeutics Production and Immune Activation.
Chu-Xin Li, Yu Zhang, Xue Dong, Lu Zhang, Miao-Deng Liu, Bin Li, Ming-Kang Zhang, Jun Feng, Xian-Zheng Zhang. Adv Mater 2019
69
10

MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma.
Meiying Wu, Haixian Zhang, Changjun Tie, Chunhong Yan, Zhiting Deng, Qian Wan, Xin Liu, Fei Yan, Hairong Zheng. Nat Commun 2018
85
8

Harnessing the Formation of Natural Killer-Tumor Cell Immunological Synapses for Enhanced Therapeutic Effect in Solid Tumors.
Sooseok Im, Donghyun Jang, Gurusamy Saravanakumar, Junseok Lee, Yeoul Kang, Yeong Mi Lee, Jaehyun Lee, Junsang Doh, Zung Yoon Yang, Myoung Ho Jang,[...]. Adv Mater 2020
16
43

A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors.
Mi-Ran Choi, Katie J Stanton-Maxey, Jennifer K Stanley, Carly S Levin, Rizia Bardhan, Demir Akin, Sunil Badve, Jennifer Sturgis, J Paul Robinson, Rashid Bashir,[...]. Nano Lett 2007
349
7

Doxil®--the first FDA-approved nano-drug: lessons learned.
Yechezkel Barenholz. J Control Release 2012
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.